RAFFA WEALTH MANAGEMENT, LLC’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$360K Buy
1,432
+4
+0.3% +$861 0.05% 71
2026
Q1
$311K Buy
1,428
+47
+3% +$10.4K 0.05% 75
2025
Q4
$315K Buy
1,381
+257
+23% +$58.5K 0.05% 75
2025
Q3
$260K Sell
1,124
-218
-16% -$44.4K 0.05% 80
2025
Q2
$249K Buy
1,342
+217
+19% +$40.3K 0.05% 82
2025
Q1
$236K Sell
1,125
-43
-4% -$8.36K 0.05% 74
2024
Q4
$207K Buy
1,168
+251
+27% +$46.1K 0.05% 76
2024
Q3
$181K Hold
917
0.04% 81
2024
Q2
$157K Hold
917
0.04% 100
2024
Q1
$167K Buy
+917
New +$158K 0.05% 97
2023
Q3
$152K Buy
+1,018
New +$149K 0.05% 77
2022
Q4
$62.9K Buy
389
+20
+5% +$3.07K 0.03% 119
2022
Q3
$49.5K Buy
+369
New +$53K 0.02% 131
2021
Q4
$56.1K Sell
414
-24
-5% -$2.83K 0.02% 145
2021
Q3
$47.2K Buy
438
+27
+7% +$3.08K 0.02% 135
2021
Q2
$46.3K Buy
+411
New +$46.3K 0.02% 144
2020
Q4
$39.4K Buy
+368
New +$35.4K 0.01% 143
2020
Q2
$23.6K Buy
240
+34
+17% +$2.99K 0.01% 161
2020
Q1
$15.7K Buy
+206
New +$17.5K 0.01% 168
2019
Q3
$30.2K Buy
+399
New +$27.4K 0.01% 168
2018
Q1
$14.5K Buy
153
+116
+314% +$12.7K 0.01% 189
2017
Q4
$3.58K Buy
+37
New +$3.49K ﹤0.01% 229
2016
Q3
$8.7K Buy
+138
New +$8.93K ﹤0.01% 186
2016
Q1
$78.9K Hold
1,381
0.05% 73
2015
Q4
$81.8K Buy
+1,381
New +$79.5K 0.05% 66
2015
Q2
$86.1K Buy
1,281
+1,250
+4,032% +$81.6K 0.05% 67
2015
Q1
$1.81K Sell
31
-5
-14% -$302 ﹤0.01% 282
2014
Q4
$2.36K Hold
36
﹤0.01% 238
2014
Q3
$2.08K Buy
+36
New +$2K ﹤0.01% 251
2014
Q1
Sell
-36
Closed -$2.36K 275
2013
Q4
$2.36K Buy
+36
New +$1.77K ﹤0.01% 238

Other funds holding ABBV

RAFFA WEALTH MANAGEMENT, LLC's ABBV Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC increased its AbbVie (ABBV) stake by 0.28% in Q2 2026, buying an estimated $861 and bringing the position to 1,432 shares worth $360K. The position accounts for 0.05% of the portfolio, ranked #71.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in ABBV in Q4 2013 and has held it in 30 quarters since. 1,601 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • RAFFA WEALTH MANAGEMENT, LLC held 1,432 shares of AbbVie worth $360K as of Q2 2026.
  • RAFFA WEALTH MANAGEMENT, LLC bought 4 AbbVie shares in Q2 2026, an estimated $861.
  • AbbVie made up 0.05% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #71 holding.
  • RAFFA WEALTH MANAGEMENT, LLC first reported a position in AbbVie in Q4 2013 and has held it in 30 quarters since.
  • 1,601 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.